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Abstract
Background: Preoperative clinical diagnosis of lymph node (LN) metastasis and subsequent pathological diagnosis are
often not in agreement. Detection of false-negative LNs is essential in selecting an optimal treatment strategy, and
most importantly, the presence of false-negative LN is itself a significant prognostic indicator. Therefore, at present,
there is an urgent need to establish more accurate and individualized evaluation methods for LN metastasis.
Methods: Of 213 cN0 patients who underwent curative esophagectomy without preoperative neoadjuvant treatment,
60 (28%) had LN metastasis diagnosed pathologically. There were 129 false-negative LNs, of which 85 were detectable
by preoperative computed tomography (CT). We retrospectively investigated the distribution, frequency, and
characteristics of pathologically positive nodes in patients with clinically N0 esophageal cancer.
Results: The paracardial region was the most frequent region of false-negative LNs, accounting for 26% (22 LNs) of the
total incidence. False-negative LNs distributed widely from the neck to the abdomen in patients with a primary tumor
in the middle thoracic esophagus. In patients with a primary tumor in the lower thoracic esophagus, four false-
negative LNs were detected in the superior mediastinum. When the short-axis diameter, shape, and attenuation
patterns of the LNs were used as criteria for metastasis diagnosis, they were insufficient for an accurate diagnosis.
However, false-negative LNs in the most frequently occurring sites are characterized by smaller short-axis, suggesting
that accurate diagnosis cannot be made unless the diagnostic criteria for the short-axis are reduced in addition to
shape and attenuation.
Conclusions: Although restrictive to the most frequent regions of false-negative LNs occur, reducing size criterion and
consideration of their shape and attenuation may contribute to improved diagnosis.
Keywords: False-negative lymph node, Lymph node metastasis, Esophageal cancer
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Background
Regardless of advances in the comprehensive treatment
of esophageal cancer, overall survival and preoperative
5-year survival remain poor [1, 2]. Lymph node stage is
a key independent prognostic indicator in esophageal
cancer. Beyond that, both the number and specific distri-
bution of LN metastasis have been considered significant
prognostic factors [3, 4]. For superficial esophageal
cancer without LN metastasis, endoscopic mucosal re-
section (EMR) or endoscopic submucosal dissection
(ESD) has shown results comparable to esophagectomy
[5, 6]. In cases of locally advanced esophageal cancer
without distant metastasis, the surgical approach and po-
tential application of neoadjuvant therapy are dependent
on the preoperative evaluation. Consequently, an accur-
ate evaluation to identify those patients most likely to
benefit from surgical intervention and those that are
sufficient with minimally invasive treatment preserving
esophagus is essential.
The presence of false-negative LNs hinders the actual
cancer status and selection of an appropriate treatment.
Despite its importance, preoperative clinical LN diagno-
sis and final pathological evaluation are often inconsist-
ent [7]. In an earlier study, the rate of false-negative LN
metastasis was reported to be 11–56% [8]. Clearly, a
more accurate and individualized method or new criteria
for conventional radiologic imaging are urgently re-
quired. To address this issue, we investigated the distri-
bution, frequency, and characteristics of pathologically




Between 2003 and 2016, 613 consecutive patients with
thoracic esophageal cancer received esophagectomy at
Akita University Hospital. Of those, 213 patients were
diagnosed with cN0 thoracic esophageal cancer and
received esophagectomy with extended 3-field lymphad-
enectomy without preoperative neoadjuvant therapy.
Pathological diagnosis of 60 cN0 thoracic esophageal
cancer patients showed positive LN metastasis. We en-
rolled those 60 patients in this study and retrospectively
evaluated pathologically metastatic LNs and the patients’
clinical outcomes. Exclusion criteria were patients clinic-
ally diagnosed with LN metastasis and patients who
received preoperative neoadjuvant chemotherapy or che-
moradiotherapy. Informed consent for use of CT data
for analysis was obtained from all patients included in
the present study.
Computed tomography scanning procedure
During the study period, we used two types of CT scan-
ners: Discovery CT750HD or Discovery CT750HDA
(GE Healthcare Japan, Tokyo, Japan). All patients were
scanned from the neck to the pelvis. CT images were
obtained using the helical technique with patients in a
supine position. Slices with thicknesses of 1.25 mm (thin
slice) and 5mm were obtained before and after intraven-
ous injection of 100 ml of non-ionic, iodinated contrast
medium at 300–350 mg/ml. For contrast administration,
we used an automatic injector that was set to deliver the
contrast medium for 60 s. Scanning was begun at 95 s.
Clinical diagnosis of LN metastasis in CT
Traditionally, LNs with short diameters ≥ 10 mm are
considered to have cancer infiltration [9–11]. However,
given the consistent frequency of metastatic nodes with
short axes smaller than 10mm, we reasoned that lower-
ing the size criteria may contribute to more accurate
diagnosis. In addition, metastatic LNs reportedly tend to
be round [12], so combining axial ratio and LN size
would be expected to increase sensitivity [13]. In the
present study, therefore, LNs were diagnosed as meta-
static when the short axis diameter was ≥ 8 mm, the
shape of the node was round, and the internal density
was heterogeneous. A preoperative diagnosis of LN me-
tastasis was made by a multidisciplinary tumor board
composed of gastroenterologists, surgeons, radiologists,
oncologists, and pharmacists. The classification of re-
gional LN station was made according to the Japanese
Guidelines for Clinical and Pathologic Studies on Car-
cinoma of the Esophagus [14, 15], as presented in Table
1. Clinical TNM stage was determined according to the
international Union against Cancer tumor-node-
metastasis (TMN) Classification of Malignant Tumors
(seventh edition) [16].
Pathological examination for LN metastasis
For pathological examination, each LN was fixed in
20% buffered formalin, embedded in paraffin, sectioned,
and stained with hematoxylin and eosin. Further inves-
tigation with immunohistochemical staining was
performed for LNs that raised suspicion of cancer
involvement. All dissected LNs were microscopically
analyzed for metastatic disease by pathologists. Histo-
pathological findings were classified according to the
UICC TNM classification [16].
Evaluation of LNs in this study
For each false-negative LN diagnosed microscopically,
one-to-one correlation was made retrospectively with
preoperative CT images. Lymph nodes not visualized by
preoperative CT were excluded from the evaluation be-
cause of inconsistency with CT-pathological correlations.
Lymph node size, configuration, and CT attenuation were
measured to define the features of the false-negative LNs.
We also evaluated the presence of the CT angiogram sign
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within the lesion in both the 1.25-mm thin slice and 5-
mm slice axial images. To determine the size and config-
uration of the LNs, the long and short axes were
measured, and the long-to-short axis ratios were calcu-
lated. The CT attenuation values of the nodes were com-
pared with that of muscle attenuation and classified as
hyper-, iso-, or hypo-attenuating.
Surgery
Our standard operative procedure is right transthoracic or
thoracoscopic esophagectomy with extended 3-field lymph-
adenectomy (bilateral neck including supraclavicular LN
and mediastinal and abdominal lymph nodes). We com-
monly perform reconstruction by inserting a gastric tube
via the posterior mediastinal or the retrosternal route.
Table 1 Terminology used for lymph nodes in esophageal cancer
LN station No. Location
Neck
No. 100 Superficial lymph nodes of the neck
No. 101 Cervical paraesophageal lymph nodes
No. 102 Deep cervical lymph nodes
No. 103 Peripharyngeal lymph nodes
No. 104 Supraclavicular lymph nodes
Mediastinum
No. 105 Upper thoracic paraesophageal lymph nodes
No. 106rec Recurrent nerve lymph nodes
No. 106pre Pretracheal lymph nodes
No. 106tb Tracheobronchial lymph nodes
No. 107 Subcarinal lymph nodes
No. 108 Middle thoracic paraesophageal lymph nodes
No. 109 Main bronchus lymph nodes
No. 110 Lower thoracic paraesophageal lymph nodes
No. 111 Supradiaphragmatic lymph nodes
No. 112aoA Anterior thoracic paraaortic lymph nodes
No. 112aoP Posterior thoracic paraaortic lymph nodes
No. 112pul Pulmonary ligament lymph nodes
Abdomen
No. 1 Right paracardial lymph nodes
No. 2 Left paracardial lymph nodes
No. 3 Lesser curvature lymph nodes
No. 4sa Lymph nodes along the short gastric vessels
No. 4sb Lymph nodes along the left gastroepiploic artery
No. 4d Lymph nodes along the right gastroepiploic artery
No. 5 Suprapyloric lymph nodes
No. 6 Infrapyloric lymph nodes
No. 7 Lymph nodes along the left gastric artery
No. 8a Lymph nodes along the common hepatic artery (anterosuperior group)
No. 8p Lymph nodes along the common hepatic artery (posterior group)
No. 9 Lymph nodes along the celiac artery
No. 10 Lymph nodes at the splenic hilum
No. 11p Lymph nodes along the proximal splenic artery
No. 11d Lymph nodes along the distal splenic artery
No. 12 Lymph nodes in the hepatoduodenal ligament
The left (L) and right (R) sides are considered separately for Nos. 101, 102, 104, 106rec, and 112pul
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Statistical analysis
Continuous variables are presented as medians (mini-
mum-maximum). Categorized data were analyzed using
the Pearson’s Chi square test or Fisher’s exact probabil-
ity test. All statistical analysis was performed using JMP
11 (SAS Institute Inc., Cary, NC, USA) and yielded two-




The patients’ clinicopathological characteristics are sum-
marized in Table 2. Of 213 cN0 patients who underwent
curative esophagectomy without neoadjuvant treatment,
60 (28%) had total of 129 pathologically diagnosed meta-
static LNs. That patient population included 51 (85%)
males and 9 (15%) females with a median age of 67 years
(range, 51–85 years). Four (7%) of the tumors were in
the upper thoracic esophagus, 33 (55%) were in the mid-
dle thoracic segment, and 23 (38%) were in the lower
thoracic segment. The median tumor size was 40mm
(range, 10–95mm). The depth of the tumor invasion
was pT1 in 29 (48%) patients, T2 in 7 (12%) patients, T3
in 22 (37%) patients, and T4 in 2 (3%) patients. Histo-
logical findings showed that in 49 (82%) patients the
tumor was a squamous cell carcinoma, while in 5 (8%)
patients it was an adenocarcinoma.
Frequency and most likely locations of false-negative LNs
At total of 129 false-negative LNs were detected in 60
patients. Retrospectively examined, 85 (66%) of the LNs
were visualized in the preoperative enhanced CT. Their
distribution is summarized in Fig. 1. Sixteen (18.8%)
false-negative LNs were detected in the right paracar-
dial region. This was followed in descending order by
the lesser curvature LNs (15/85, 17.6%), left recurrent
nerve LNs (10/85, 11.8%), and right recurrent nerve
LNs (7/85, 8.2%).
Locations of false-negative LNs and the primary tumors
The regions of false-negative LNs in patients with primary
tumors in the upper, middle, or lower thoracic esophagus
are summarized in Fig. 2. In patients with upper thoracic
esophageal cancer, all five false-negative LNs were located
within superior mediastinal region, four were left recur-
rent LNs, and 1 was a left tracheobronchial LN. In pa-
tients with a primary tumor in the middle thoracic
esophagus, 46 false-negative LNs were widely distributed
from the neck to the abdomen. In patients with a primary
tumor in the lower thoracic esophagus, four of 34 false-
negative LNs were detected in the superior mediastinal re-
gion. Three were right recurrent nerve LNs, and one was
a left recurrent nerve LN.
Size, shape, and attenuation values of false-negative LNs
Features of false-negative LNs evaluated by CT are
shown in Table 3. Understandably, 76 (89%) of the false-
negative LNs did not exceed 8 mm in size. The long-to-
short axis ratio was less than 2 in 73 (86%) of the 85
LNs. Fifty nodes (59%) were iso-attenuated, and 16
(19%) were hypo-attenuated. With addition of shape
(round) and attenuation (iso-hypo) to the criteria for
false-negative LNs, still only 5 (6%) of the 85 false-
negative LNs would be regarded as metastatic. Particu-
larly, 50–56% of false-negative LNs in the paracardial
region had short diameters less than 5 mm and long-to-
short axis ratios of less than 2, and they were iso-hypo-
attenuated (Figs. 3 and 4). Upon further addition of a
reduced CT size criterion (≥ 5 mm) for false-negative
LNs in the most frequent locations, 16 (30%) of the 54
false-negative LNs would be regarded as metastatic.
Discussion
Our present study demonstrates that 28% of patients
who underwent esophagectomy with LN dissection
without neoadjuvant treatment had LNs falsely diag-
nosed as negative for metastasis, which is consistent with
an earlier study [8]. False-negative LNs were most recog-
nized in paracardial (Nos.1, 2) and paratracheal (No.106)
region. In addition, it was shown that false-negative LNs
in the most frequent region were smaller than those in
other regions.
Due to the complex development of the lymphatic net-
work around the esophagus, LN metastasis of thoracic
esophageal cancer widely distributes from the neck to
the abdomen [17, 18]. Indeed, our study showed that
false-negative LNs were not limited to the vicinity of the
primary tumor. Our assessments of nodal metastasis,
taking into consideration the location of primary tumor,
showed that false-negative LNs associated with middle
thoracic esophageal tumors distributed broadly from the
neck to abdomen. Moreover, in patients with a primary
tumor in the lower thoracic esophagus, false-negative
LNs were detected even in the superior mediastinum.
Among the various regions for possible LN metastasis,
false negatives were most frequently detected among the
paracardial (Nos.1, 2) and paratracheal (No.106) LNs
(26% and 22%, respectively). Focusing on the most
frequent region (paracardial; Nos.1, 2), 50–56% of false-
negative LNs were small (< 5 mm). This suggests that in
the frequent regions of false-negative LNs, even small
LNs may be metastatic when they are roundish and iso-
hypo-attenuated. Because LN metastases are often
microscopic, the cancer-involved nodes may be small, as
in these cases. Kajiyama et al. reported that 37.2% of
metastatic LNs were < 5 mm in diameter [19]. This
makes diagnosis difficult at the preoperative stage.
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Table 2 Clinicopathological features of cN0 esophageal cancer patients
All patients (n = 213) Lymph node involvement p









Tumor size (mm) 40 (10–95) 35 (10–106) 0.146




















Squamous cell carcinoma 49 141
Adenocarcinoma 5 6
Other 6 6
Tumor differentiation of SCC





Alive 40 124 0.017*
Deceased from esophageal ca. 10 7
Deceased from other ca. 0 4
Deceased from other diseases 10 18
*Statistically significant
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Modalities such as endoscopic ultrasound (EUS), CT,
and FDG-positron emission tomography (FDG-PET) are
frequently used for LN diagnosis, and previous studies
report that their diagnostic performance is not satisfac-
tory. The results of meta-analyses have shown that EUS
improves the sensitivity of LN diagnosis of metastasis
from 84.7 to 96.7% when combined with fine needle
aspiration (FNA) [20–22] but is limited to evaluation of
LNs in the proximity of the esophageal or gastric wall.
FDG-PET has the disadvantage that LNs adjacent to the
tumor are difficult to discriminate from the tumor itself
because of poor spatial resolution. Furthermore, FGD-
PET is not suitable for diagnosis of small lymph node
metastasis. FDG-PET has been reported to be detectable
in tumors with a diameter ≥ 6 mm or tumors measuring
≥ 33mm2 [23, 24], making it difficult to diagnose small
metastatic LNs.
CT scanning is the noninvasive and most common
modality used to evaluate metastatic infiltration of LNs
in esophageal cancer. Although detection of LN metasta-
sis on CT depends primarily on the size criteria, past
reports have shown that the sensitivity of CT is
Fig. 1 Distribution of false-negative LNs visualized on CT. Among the 85 false-negatives, the right paracardial LNs were most frequently
metastatic (18.8%, 16/85LNs), followed by lesser curvature LNs (17.6%, 15/85LNs) and left recurrent nerve LNs (11.8%, 10/85LNs)
Fig. 2 Distributions of false-negative LNs and location of the primary tumors. False-negative LNs associated with upper thoracic tumors were
found in the superior mediastinal region. By contrast, with middle and lower thoracic tumors, false-negative LNs were detected in all three fields
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unsatisfactory when LNs greater than 10 mm are consid-
ered positive for metastasis [23, 25, 26]. Short axis diam-
eter alone is insufficient for detection of normally sized
metastatic LNs, nor can it distinguish between reactive
hyperplasia and metastatic enlargement [27]. We there-
fore included the shape and attenuation patterns of the
nodes to verify the presence of LN metastasis. The re-
sults show that using these parameters improves
detection of metastatic LNs within areas where the
frequency of false-negative LNs is comparatively high.
We assume that CT scanning will continue to play a
dominant role with the introduction of artificial
intelligence, when not only the size, but also clinical
factors such as the distribution of false-negative LNs and
their frequent regions will be considered for determin-
ation of LN metastasis. However, despite the technological
advances made so far, diagnosis of LN metastasis using
CT remains unsatisfactory [28], and the precise role of CT
for assessing disease in a preoperative setting is still under
discussion.
In order to diagnose metastatic LNs more accur-
ately, further research and establishment of other
methods that supplement the limitations of diagnostic
imaging are also expected. We previously reported
that the CRP 1846C>T genetic polymorphism is an
independent factor associated with LN metastasis in
thoracic esophageal squamous cell carcinoma. Patients
carrying the CRP 1846 T/T genotype showed LN me-
tastasis significantly more frequently than those with
other genotypes. Moreover, the specificity was 91%
for cN0 patients diagnosed using CT combined with
CRP genetic polymorphism [29]. This combination
may thus be a useful new approach to evaluating the
risk of LN metastasis.
Our study has limitations including the nature of the
retrospective study design. This study did not examine











Sphere 1 (1.2%) 9 (10.6%) 20 (23.5%)
Oval 2 (2.4%) 23 (27.1%) 18 (21.2%)
Flat 0 8 (9.4%) 4 (4.7%)
Size (short axis) of LN (mm)
≥ 10 0 1 (1.2%) 1 (1.2%)
< 10 3 (3.5%) 39 (45.9%) 41 (48.2%)
≥ 8 0 2 (2.4%) 7 (8.2%)
< 8 3 (3.5%) 38 (44.7%) 35 (41.2%)
≥ 5 2 (2.4%) 19 (22.3%) 21 (24.7%)
< 5 1 (1.2%) 21 (24.7%) 21 (24.7%)
Attenuation
Hypo- 0 8 (9.4%) 8 (9.4%)
Iso- 3 (3.5%) 22 (25.9%)) 25 (29.4%)
Hyper- 0 10 (11.8%) 9 (10.6%)
Fig. 3 Focusing on the paracardial region, where LN metastasis most frequently occurred, 50–56% of false-negative LNs were small (< 5 mm),
oval, and iso-hypo attenuated. This highlights the difficulty of diagnosing LN metastasis in this region
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all cN0 patients who were pathologically positive for LN
metastasis but limited them to those who did not receive
preoperative neoadjuvant therapy. This could potentially
affect accurately evaluating the characteristics of false-
negative LNs.
Conclusion
In summary, the accuracy of anatomical imaging for
diagnosis of LN metastasis is yet not satisfactory. Careful
consideration is therefore needed, especially for diagno-
sis of LNs in the paracardial (No.1, 2) and paratracheal
(No.106) regions. Limited to the most frequent regions
of false-negative lymph nodes occur, reducing size criter-
ion and consideration of their shape and attenuation
may result in more accurate lymph node diagnosis.
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